New study tests switching IBD patients from IV to home injections
NCT ID NCT06381518
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This study involved 38 adults with inflammatory bowel disease (Crohn's or colitis) whose disease was under control with intravenous (IV) infliximab. Researchers switched them to a subcutaneous (under-the-skin) version of the same medication to see if drug levels, effectiveness, and patient satisfaction stayed similar. The goal was to make treatment more convenient without losing disease control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zuyderland Medical Centre
Sittard, Netherlands
Conditions
Explore the condition pages connected to this study.